POLL: Are you concerned about the recent black box warning given to JAK inhibitors?

Click here to answer our weekly poll.

Are you concerned about the recent black box warning given to upcoming JAK inhibitors baricitinib and upadacitinib?

Yes
No
Only a little
Related Content

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

March 21st 2023

POLL: What Will Catch Your Eye In The AAD Exhibit Hall?

March 15th 2023

POLL: What Are You Most Looking Forward to at AAD 2023?

March 14th 2023

POLL: Are You Attending AAD 2023?

March 13th 2023

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

POLL: What is the Most Common Type of Mole Found on Adults?

February 27th 2023

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

March 21st 2023

POLL: What Will Catch Your Eye In The AAD Exhibit Hall?

March 15th 2023

POLL: What Are You Most Looking Forward to at AAD 2023?

March 14th 2023

POLL: Are You Attending AAD 2023?

March 13th 2023

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

POLL: What is the Most Common Type of Mole Found on Adults?

February 27th 2023

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

March 21st 2023

POLL: What Will Catch Your Eye In The AAD Exhibit Hall?

March 15th 2023

POLL: What Are You Most Looking Forward to at AAD 2023?

March 14th 2023

POLL: Are You Attending AAD 2023?

March 13th 2023

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

POLL: What is the Most Common Type of Mole Found on Adults?

February 27th 2023
© 2023 MJH Life Sciences

All rights reserved.